
Call us
07971549588
GEFISTERIS 250 is a potent medication designed to combat non-small cell lung cancer (NSCLC). It contains Gefitinib (250mg) as its active ingredient, which belongs to a class of drugs known as tyrosine kinase inhibitors. This medication is specifically formulated to target and inhibit the activity of a specific protein involved in the growth and spread of cancer cells, offering a promising treatment option for patients diagnosed with NSCLC.
Price: